Liver fibrosis develops when scar tissue accumulates in the liver as a result of ongoing or repeated injury or inflammation. Nearly all forms of chronic liver disease can eventually lead to fibrosis1
The scar tissue that develops with MASH cannot repair itself or function properly, unlike the healthy liver cells. As a consequence, fibrosis can disrupt the normal structure and function of the liver, including the liver's ability to regenerate2.
Additionally, scar tissue from fibrosis can obstruct or restrict blood flow within the liver, depriving healthy liver cells of nutrients, which can lead to the formation of even more scar tissue. If fibrosis progresses to cirrhosis, liver damage may be irreversible3.
Blood Tests
Blood tests can be used to determine the level of scarring or fibrosis and help distinguish between the severity of the disease2. Two common blood-tests used is the FIB-45, which is used to assess the risk of advanced MASH and the ELF test4, which is used to assess the level of clinically significant fibrosis.
Image Tests
Transient elastography6 is a special type of ultrasound, that is used to measure liver stiffness. Stiffness is a typical sign of scarring or fibrosis caused by MASH.
Liver Biopsy
In some cases a liver biopsy may be required to determine the level of scarring. It is an invasive procedure associated with complications in 1–3% of cases2.
MASLD, marked by excess fat in the liver, can develop into MASH, where liver cells become damaged.
Over time, this can lead to fibrosis (scarring), known as MASH with fibrosis. The most severe stage is cirrhosis, characterized by extensive scarring.
MASH with no/mild fibrosis
This is the early stage where there is excess fat in the liver, inflammation and cell injury.
MASH with moderate fibrosis
At this stage, there is more noticeable scarring in the liver.
MASH with advanced fibrosis
Here, the scarring in the liver is significant. The liver's ability to function is more affected.
Cirrhosis
This is the most severe stage, where the liver is heavily scarred.
MASH and MASLD are updated terms for conditions previously known as NASH (non-alcoholic steatohepatitis) and NAFLD (non- alcoholic fatty liver disease). Similarly, "steatotic liver disease" is the current term for what was once called "fatty liver disease".